Given the link between elevated brain natriuretic peptide (BNP) levels, subclinical brain injury, and dementia, managing heart failure effectively with BNP and other biomarkers to guide therapy is crucial for preserving cerebral tissue perfusion [2]. The gene discussed is NPPB; the disease is heart failure.